---
title: >-
  Ceo of Global Pharmaceutical Giant Merck, Ken Frazier, Speaking About a
  Potential Covid-19 Treatment.
slug: >-
  20200527-ceo-of-global-pharmaceutical-giant-merck-ken-frazier-speaking-about-a-potential-covid-19-treatment
_id: legacy-95d1285e-5bb1-43c0-92b4-d54f1586cc39
_rev: XOnQP8cIThhnw9BWFxVLuz
type: quick_quotes
draft: false
aliases:
  - >-
    article/ceo-of-global-pharmaceutical-giant-merck-ken-frazier-speaking-about-a-potential-covid-19-treatment/
_createdAt: '2020-05-28T01:58:20Z'
_updatedAt: '2021-03-16T12:32:42Z'
date: '2020-05-28T01:58:20+00:00'
weight: 50
is_breaking: false
summary: >-
  CEO of global pharmaceutical giant Merck, Ken Frazier, speaking about a
  potential COVID-19 treatment.
featured_quote:
  quote: >-
    We understand the urgency, but our goal isn’t to be the frontrunner in the
    early stages — it’s to develop a vaccine that is safe and effective.
  citation: >-
    CEO of global pharmaceutical giant Merck, Ken Frazier, speaking about a
    potential COVID-19 treatment.

---
* [Frazier](https://www.merck.com/about/leadership/board-of-directors/home.html) recently did a series of interviews as the company continues to push into the competitive space for a COVID-19 treatment.
* Merck recently bought a European company working on a COVID-19 vaccine.
* Merck also partnered with a smaller U.S. company working on an antiviral treatment for COVID-19; unlike remdesevir, this treatment does not have to be administered through an IV.
* **Why It Matters:** Frazier, although optimistic about COVID-19 pharmaceuticals, underscored the need for safety and efficiency when millions – and potentially billions – of people may eventually need the treatments developed. He said in an interview with _The Financial Times_ that 12-18 months to develop a safe and effective vaccine was “very aggressive” and a timeline he did not want to commit his company too.

Read more of his _Financial Times_ interview [HERE](https://www.ft.com/content/7b72a568-9eed-460f-b100-7bf74e3f4cbf)ead more of his _Financial Times_ interview [HERE](https://www.ft.com/content/7b72a568-9eed-460f-b100-7bf74e3f4cbf)